Results 41 to 50 of about 42,544 (264)
Journal of General Virology, 1979 A radioimmunoassay for hepatitis B e-antigen (HBeAg) is described. Polystyrene beads coated with IgG prepared from a human serum containing antibodies to HBeAg (anti-HBe) and anti-HBe IgG labelled with 125I-p-hydroxyphenylpropionic acid N-hydroxysuccinimide ester were used in the test.
A R, Neurath +4 more
openaire +2 more sources
AUC of ALT associated with significant histological characteristics in HBeAg positive and HBeAg negative patients. [PDF]
, 2015 A: AUC of ALT associated with significant necroinflammatory scores in HBeAg positive patients; B: AUC of ALT associated with significant fibrosis scores in HBeAg positive patients; C: AUC of ALT associated with significant necroinflammatory scores in ...
Li Chen (5749) +4 more
core +1 more source
Emerging Microbes and Infections, 2021 Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB) clinical management and HBV-related basic research. However, due to its high amino acid sequence homology to hepatitis B core antigen (HBcAg), most of available anti-
Shao-Juan Wang +17 more
doaj +1 more source
Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion [PDF]
, 2009 Background: Recent evidence suggests that delayed HBeAg seroconversion is associated with poorer outcome. We aim to determine the incidence of HBeAg-negative chronic hepatitis B (CHB) according to the age at which HBeAg seroconversion occurs. Methods:
Fung, JYY +4 more
core +1 more source
HBeAg sero-negative patients displayed lower HBV DNA level than HBeAg sero-positive patients. [PDF]
, 2015 HBeAg sero-negative patients displayed lower HBV DNA level than HBeAg sero-positive patients.
Ling Zhao (111365) +7 more
core +1 more source
The prevalence of hepatitis B virus E antigen among Ghanaian blood donors
The Pan African Medical Journal, 2014 Hepatitis B viral infection is an important clinical problem due to its worldwide distribution and potential of adverse sequelae, including hepatocellular carcinoma (HCC). We studied the prevalence of hepatitis B virus e antigen (HBeAg) among individuals
Tanko Rufai +3 more
doaj +1 more source
Hepatology, 2019 The optimal management strategy for children with immune‐tolerant chronic hepatitis B virus (HBV) infection remains unknown. The purpose of this clinical trial was to determine the safety and efficacy of therapy with entecavir and peginterferon in a ...
P. Rosenthal +8 more
semanticscholar +1 more source
Di-san junyi daxue xuebao, 2022 Objective To analyze the clinical features of HBeAg and HBeAb double-positive patients with chronic hepatitis B, and explore the efficacy and outcomes of different antiviral regimens.
AN Xuan +6 more
doaj +1 more source
Difference in the incidence of YMDD mutation between HBeAg positive and HBeAg negative patients. [PDF]
, 2012 Difference in the incidence of YMDD mutation between HBeAg positive and HBeAg negative patients.
Li Chen (5749) +10 more
core +1 more source
Scientific Reports, 2021 Tenofovir and entecavir are currently designated as the preferred oral antiviral drugs for chronic hepatitis B. However, only less than 40% of patients can achieve HBeAg seroconversion.
Yu-Li Zeng +15 more
doaj +1 more source